The U.S. Food and Drug Administration is voluntarily recalling a blood pressure medication after an impurity classified as a cancer-causing chemical was found.

According to the FDA, Losartan Potassium Hydrochlorothiazide Tablets, USP are indicated for the treatment of hypertension.

The recall includes 100 milligram/25 milligram tablets with the lot number JB8912.

CNN reports, the drug is being recalled because the active ingredient has tested positive for N-Nitrosodiethylamine, or NDEA, a suspected human and animal carcinogen that is used in gasoline as a stabilizer for industry materials and as a lubricant additive, according to the National Institutes of Health.

For more information or to report an issue with the medication click HERE.

Written by NBC4 Staff for WCMH-TV, Columbus ~ November 13, 2018

FAIR USE NOTICE: This site contains copyrighted material the use of which has not always been specifically authorized by the copyright owner. We are making such material available in our efforts to advance understanding of environmental, political, human rights, economic, democracy, scientific, and social justice issues, etc. We believe this constitutes a ‘fair use’ of any such copyrighted material as provided for in section 107 of the US Copyright Law. In accordance with Title 17 U. S. C. Section 107, the material on this site is distributed without profit to those who have expressed a prior interest in receiving the included information for research and educational purposes. For more information go to: http://www.law.cornell.edu/uscode/17/107.shtml